[1]张 勇.阴道放置米索前列醇在终止6~10周妊娠负压吸宫术前的应用[J].医学信息,2019,32(24):143-144.[doi:10.3969/j.issn.1006-1959.2019.24.051]
　ZHANG Yong.Application of Vaginal Misoprostol Before Termination of Negative Pressure Uterine Aspiration with 6 to 10 Weeks[J].Medical Information,2019,32(24):143-144.[doi:10.3969/j.issn.1006-1959.2019.24.051]
点击复制

阴道放置米索前列醇在终止6~10周妊娠负压吸宫术前的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年24期
页码:
143-144
栏目:
药物与临床
出版日期:
2019-12-15

文章信息/Info

Title:
Application of Vaginal Misoprostol Before Termination of Negative Pressure Uterine Aspiration with 6 to 10 Weeks
文章编号:
1006-1959（2019）24-0143-02
作者:
张 勇
（南昌市新建区人民医院妇产科，江西 南昌 330100）
Author(s):
ZHANG Yong
(Department of Obstetrics and Gynecology,Xinjian District People’s Hospital,Nanchang 330100,Jiangxi,China)
关键词:
米索前列醇; 米非司酮; 负压吸宫术; 早期妊娠; 并发症
Keywords:
Misoprostol; Mifepristone; Negative pressure aspiration; Early pregnancy; Complications
分类号:
R169.42
DOI:
10.3969/j.issn.1006-1959.2019.24.051
文献标志码:
A
摘要:
目的 探讨米索前列醇在终止6~10周妊娠负压吸宫术前的应用效果。方法 选取2018年5月~2019年5月我院收治的终止6~10周妊娠患者129例，按照随机数字表法分为对照1组、对照2组和研究组，每组43例。对照1组术前不使用药物干预，对照2组术前口服米索前列醇片联合米非司酮进行干预，研究组术前3 h阴道放置米索前列醇干预，比较三组宫颈软化程度、手术情况、出血量、人流综合征、术后疼痛、宫颈粘连及感染发生情况。结果 研究组宫颈软化有效率高于对照1组、对照2组（P＜0.05）；对照2组宫颈软化有效率高于对照1组（P＜0.05）；研究组手术时间、出血量、疼痛以及人流综合征发生低于对照1组、对照2组，且对照2组低于对照1组（P＜0.05）；研究组并发症发生率低于对照1组、对照2组，且对照2组并发症发生率低于对照组1组（P＜0.05）。结论 对于接受负压吸宫术治疗的妊娠10周内患者，术前3 h阴道置入米索前列醇进行治疗，可以有效提高患者宫颈软化效果，缩短手术时间，减少出血量，降低术后疼痛以及人流综合征的发生，提高负压吸宫术的治疗安全性，可在临床中进一步应用。
Abstract:
Objective To investigate the effect of misoprostol before termination of negative pressure uterine aspiration at 6-10 weeks of pregnancy. Methods From May 2018 to May 2019, 129 patients with termination of 6-10 weeks of pregnancy admitted to our hospital were selected and divided into control group 1, control group 2 and study group according to the random number table method,with 43 patients in each group.The control group 1 did not use drug intervention before operation, the control group 2 took oral misoprostol tablets combined with mifepristone before intervention, and the study group intervened by placing misoprostol in the vagina 3 h before surgery. Surgery, bleeding volume, abortion syndrome, postoperative pain, cervical adhesions and infections.Results The effective rate of cervical softening in the study group was higher than that in the control group 1 and control group 2(P<0.05); the effective rate of cervical softening in the control group 2 was higher than that in the control group 1(P<0.05); the surgical time, bleeding volume, pain, and abortion syndrome in the study group were lower than those in the control group 1, control group 2, and the control group 2 were lower than the control group 1(P<0.05); the complication rate of the study group was lower than that of the control group 1 and control group 2, and the complication rate of the control group 2 was lower than that of the control group 1(P<0.05).Conclusion For pregnant women who have received negative pressure aspiration surgery within 10 weeks of pregnancy, vaginal misoprostol treatment 3 h before surgery can effectively improve the cervical softening effect, shorten the operation time, reduce bleeding volume, and reduce postoperative pain As well as the occurrence of abortion syndrome, improving the safety of negative pressure aspiration surgery can be further applied in the clinic.

参考文献/References:

[1]王蓓颖,李晓翠,王海云,等.复方米非司酮片联合米索前列醇片治疗终止10~16周妊娠及稽留流产的临床研究[J].中国临床药理学杂志,2017,33(6):499-501.[2]Raymond EG,Tan YL,Grant M,et al.Self-Assessment of Medical Abortion Outcome using Symptoms and Home Pregnancy Testing[J].Contraception,2017,97(4):324-335.[3]Cohen SM,Lipschuetz M,Yagel S,et al.Is a prolonged second stage of labour too long[J]. Ultrasound Obstet Gynecol,2017,50(4):423-426.[4]王凤玲.不同剂量米索前列醇口服和阴道给药对宫颈扩张的观察[J].中华临床医学研究杂志,2014,12(13):1742-1743.[5]刘燕,杨毓琴,王秀梅,等.米索前列醇3种给药途径用于人工流产术扩宫效果的观察[J].中国妇产科杂志,2007,15(15):553-555.

相似文献/References:

[1]陈晓娟,卢芳芳,周芳英.丙泊酚、枸橼酸舒芬太尼联合米索前列醇用于无痛人流术的效果[J].医学信息,2019,32(23):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
　CHEN Xiao-juan,LU Fang-fang,ZHOU Fang-ying.Effect of Propofol,Sufentanil citrate and Misoprostol on Painless Abortion[J].Medical Information,2019,32(24):154.[doi:10.3969/j.issn.1006-1959.2019.23.048]
[2]李 丽.米非司酮与乳酸依沙吖啶联合治疗中晚期妊娠引产的临床疗效[J].医学信息,2019,32(24):159.[doi:10.3969/j.issn.1006-1959.2019.24.058]
　LI Li.Clinical Efficacy of Mifepristone Combined with Ethacridine Lactate in the Induction of Labor in Mid-to-late Pregnancy[J].Medical Information,2019,32(24):159.[doi:10.3969/j.issn.1006-1959.2019.24.058]
[3]李晓君.麦角新碱联合米索前列醇、缩宫素在胎盘早剥产后大出血的临床效果及对应激反应的影响[J].医学信息,2023,36(19):141.[doi:10.3969/j.issn.1006-1959.2023.19.031]
　LI Xiao-jun.Clinical Effect of Ergometrine Combined with Misoprostol and Oxytocin in Postpartum Hemorrhage of Placental Abruption and its Effect on Stress Response[J].Medical Information,2023,36(24):141.[doi:10.3969/j.issn.1006-1959.2023.19.031]
[4]李 娟,胡 欣,张小妹.米非司酮联合血府逐瘀汤治疗子宫腺肌病的临床观察[J].医学信息,2021,34(23):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
　LI Juan,HU Xin,ZHANG Xiao-mei.Clinical Observation of Mifepristone Combined with Xuefu Zhuyu Decoction in the Treatment of Adenomyosis[J].Medical Information,2021,34(24):168.[doi:10.3969/j.issn.1006-1959.2021.23.051]
[5]范叶柏,宫 雪,杨晓晨.米非司酮联合甲氨蝶呤与单纯甲氨蝶呤治疗宫外孕的临床安全性和有效性比较[J].医学信息,2021,34(13):170.[doi:10.3969/j.issn.1006-1959.2021.13.047]
　FAN Ye-bai,GONG Xue,YANG Xiao-chen.Comparison of the Clinical Safety and Effectiveness of Mifepristone Combined with Methotrexate and Methotrexate Alone in the Treatment of Ectopic Pregnancy[J].Medical Information,2021,34(24):170.[doi:10.3969/j.issn.1006-1959.2021.13.047]
[6]张东霞.米非司酮在子宫内膜异位症患者腹腔镜手术中的应用研究[J].医学信息,2021,34(16):175.[doi:10.3969/j.issn.1006-1959.2021.16.050]
　ZHANG Dong-xia.Application of Mifepristone in Laparoscopic Surgery in Patients with Endometriosis[J].Medical Information,2021,34(24):175.[doi:10.3969/j.issn.1006-1959.2021.16.050]
[7]刘淑琴.米非司酮联合甲氨蝶呤治疗宫外孕的安全性和有效性分析[J].医学信息,2023,36(08):131.[doi:10.3969/j.issn.1006-1959.2023.08.028]
　LIU Shu-qin.Analysis of the Safety and Efficacy of Mifepristone Combined with Methotrexate in the Treatment of Ectopic Pregnancy[J].Medical Information,2023,36(24):131.[doi:10.3969/j.issn.1006-1959.2023.08.028]
[8]王 敏.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的效果比较[J].医学信息,2021,34(22):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
　WANG Min.Comparison of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):94.[doi:10.3969/j.issn.1006-1959.2021.22.028]
[9]张志巧.宫颈扩张球囊与米索前列醇在足月妊娠初产妇促宫颈成熟引产中的临床疗效及安全性[J].医学信息,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
　ZHANG Zhi-qiao.Clinical Efficacy and Safety of Cervical Dilation Balloon and Misoprostol in Promoting Cervical Ripening and Induction of Labor in Primiparae with Full-term Pregnancy[J].Medical Information,2021,34(24):99.[doi:10.3969/j.issn.1006-1959.2021.24.023]
[10]刘细风.甲氨蝶呤联合米非司酮治疗不同β-hCG水平宫外孕患者的效果[J].医学信息,2021,34(24):138.[doi:10.3969/j.issn.1006-1959.2021.24.035]
　LIU Xi-feng.Effect of Methotrexate Combined with Mifepristone in the Treatment of Ectopic Pregnancy with Different β-hCG Levels[J].Medical Information,2021,34(24):138.[doi:10.3969/j.issn.1006-1959.2021.24.035]
[11]周 鑫,王 明,魏 宏.药物流产终止乙肝病毒感染患者10~14周妊娠的 安全性及有效性分析[J].医学信息,2018,31(12):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]
　ZHOU Xin,WANG Ming,WEI Hong.Analysis of Safety and Effectiveness of Stopping Hepatitis B Virus Infection in 10 to 14 Weeks of Pregnancy by Drug Abortion[J].Medical Information,2018,31(24):112.[doi:10.3969/j.issn.1006-1959.2018.12.035]

更新日期/Last Update: 2019-12-15